Healthcare -
Biotechnology - NASDAQ - US
$ 14.7
4.33 %
$ 1.67 B
Market Cap
-3.88
P/E
DYN - OPERATING EXPENSES
Operating Expenses DYN - Dyne Therapeutics, Inc.
344 M
LAST VALUE
41.83%
2 YEAR CAGR
90.17%
5 YEAR CAGR
12.04%
10 YEAR CAGR